1144 related articles for article (PubMed ID: 27581985)
1. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
[TBL] [Abstract][Full Text] [Related]
2. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.
Altenburg AF; Magnusson SE; Bosman F; Stertman L; de Vries RD; Rimmelzwaan GF
Clin Exp Immunol; 2017 Oct; 190(1):19-28. PubMed ID: 28665497
[TBL] [Abstract][Full Text] [Related]
3. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.
Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC
J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172
[TBL] [Abstract][Full Text] [Related]
4. Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.
Di Mario G; Sciaraffia E; Facchini M; Gubinelli F; Soprana E; Panigada M; Bernasconi V; Garulli B; Siccardi A; Donatelli I; Castrucci MR
Pathog Glob Health; 2017 Mar; 111(2):76-82. PubMed ID: 28079473
[TBL] [Abstract][Full Text] [Related]
5. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
Kamlangdee A; Kingstad-Bakke B; Osorio JE
J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
[TBL] [Abstract][Full Text] [Related]
6. Broadly Protective CD8
Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
J Virol; 2021 May; 95(12):. PubMed ID: 33827939
[TBL] [Abstract][Full Text] [Related]
7. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
8. Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines.
Mullin J; Ahmed MS; Sharma R; Upile N; Beer H; Achar P; Puksuriwong S; Ferrara F; Temperton N; McNamara P; Lambe T; Gilbert SC; Zhang Q
Vaccine; 2016 Mar; 34(14):1688-95. PubMed ID: 26902548
[TBL] [Abstract][Full Text] [Related]
9. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
[TBL] [Abstract][Full Text] [Related]
10. Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus.
Boyd AC; Ruiz-Hernandez R; Peroval MY; Carson C; Balkissoon D; Staines K; Turner AV; Hill AV; Gilbert SC; Butter C
Vaccine; 2013 Jan; 31(4):670-5. PubMed ID: 23200938
[TBL] [Abstract][Full Text] [Related]
11. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
Altenburg AF; Rimmelzwaan GF; de Vries RD
Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice.
Asthagiri Arunkumar G; McMahon M; Pavot V; Aramouni M; Ioannou A; Lambe T; Gilbert S; Krammer F
Vaccine; 2019 Sep; 37(37):5567-5577. PubMed ID: 31399277
[TBL] [Abstract][Full Text] [Related]
13. Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge.
McMahon M; Asthagiri Arunkumar G; Liu WC; Stadlbauer D; Albrecht RA; Pavot V; Aramouni M; Lambe T; Gilbert SC; Krammer F
Front Immunol; 2019; 10():2005. PubMed ID: 31497029
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.
Valkenburg SA; Gras S; Guillonneau C; La Gruta NL; Thomas PG; Purcell AW; Rossjohn J; Doherty PC; Turner SJ; Kedzierska K
PLoS Pathog; 2010 Aug; 6(8):e1001039. PubMed ID: 20711359
[TBL] [Abstract][Full Text] [Related]
15. Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge.
Magini D; Giovani C; Mangiavacchi S; Maccari S; Cecchi R; Ulmer JB; De Gregorio E; Geall AJ; Brazzoli M; Bertholet S
PLoS One; 2016; 11(8):e0161193. PubMed ID: 27525409
[TBL] [Abstract][Full Text] [Related]
16. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
[TBL] [Abstract][Full Text] [Related]
17. Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses.
Grant E; Wu C; Chan KF; Eckle S; Bharadwaj M; Zou QM; Kedzierska K; Chen W
Immunol Cell Biol; 2013 Feb; 91(2):184-94. PubMed ID: 23399741
[TBL] [Abstract][Full Text] [Related]
18. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.
Berthoud TK; Hamill M; Lillie PJ; Hwenda L; Collins KA; Ewer KJ; Milicic A; Poyntz HC; Lambe T; Fletcher HA; Hill AV; Gilbert SC
Clin Infect Dis; 2011 Jan; 52(1):1-7. PubMed ID: 21148512
[TBL] [Abstract][Full Text] [Related]
19. Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice.
Joe PT; Christopoulou I; van Hoecke L; Schepens B; Ysenbaert T; Heirman C; Thielemans K; Saelens X; Aerts JL
J Transl Med; 2019 Jul; 17(1):242. PubMed ID: 31345237
[TBL] [Abstract][Full Text] [Related]
20. Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.
Brewoo JN; Powell TD; Jones JC; Gundlach NA; Young GR; Chu H; Das SC; Partidos CD; Stinchcomb DT; Osorio JE
Vaccine; 2013 Apr; 31(14):1848-55. PubMed ID: 23376279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
